相似文献
1
Company pushes broad-ranging patent claim.
Nat Med. 2002 Oct;8(10):1048. doi: 10.1038/nm1002-1048a.
2
Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
Science. 2006 May 12;312(5775):827. doi: 10.1126/science.312.5775.827a.
3
Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
AIDS Policy Law. 2003 Aug 29;18(16):6.
4
Industry sweats after patent verdict.
Nat Rev Drug Discov. 2006 Jun;5(6):443-4. doi: 10.1038/nrd2071.
5
Roche faces charges over Taq patent claim.
Nature. 1996 Aug 22;382(6593):660. doi: 10.1038/382660a0.
6
Patent fight sparks biological warfare in the drug industry.
Fortune. 2000 Jul 24;142(3):40, 42.
7
Patently absurd?
Nat Biotechnol. 2006 Jul;24(7):737-9. doi: 10.1038/nbt0706-737.
8
Encouraging further innovation: Ariad v. Eli Lilly and the written description requirement.
Seton Hall Law Rev. 2012;42(3):1287-36.
9
Cabilly patent finale.
Nat Biotechnol. 2008 Aug;26(8):846. doi: 10.1038/nbt0808-846b.
10
Patent crunch pending.
Nature. 2007 Oct 11;449(7163):651. doi: 10.1038/449651a.
Zotero 插件